December 29, 2025 11:14 AM
Sun Pharmaceutical Industries Ltd Tumbles -0.16% in Today's Trading Session
After a -0.16% decline, Sun Pharmaceutical Industries Ltd shares are now trading at 1716.80. The stock has a PE ratio of 39.3400, an ROE of 14.8407 and a debt to equity ratio of 0.0670.
December 29, 2025 10:16 AM
Sun Pharmaceutical Industries Ltd Stock Nosedives Today
Sun Pharmaceutical Industries Ltd stock price decreased by -0.16%, with the current market value at 1716.80 per share. Investors are assessing the stock's potential for recovery and future growth prospects.
December 29, 2025 9:16 AM
Tracking Live Updates: Sun Pharmaceutical Industries Ltd Share Price Today
Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.13%, and as of now, it's trading at 1721.80 per share. This upward trajectory is attracting keen interest from investors.
December 29, 2025 8:16 AM
Solid Jump for Sun Pharmaceutical Industries Ltd in Today's Trading Session: Share Price Climbs Up by 0.17%
After a significant 0.17% gain, Sun Pharmaceutical Industries Ltd's shares are now valued at 1722.50 in the current market. This upward movement is attracting attention from both retail and institutional investors.
December 29, 2025 7:16 AM
Solid Jump for Sun Pharmaceutical Industries Ltd in Today's Trading Session: Share Price Climbs Up by 0.36%
After a significant 0.36% gain, Sun Pharmaceutical Industries Ltd's shares are now valued at 1725.70 in the current market. This upward movement is attracting attention from both retail and institutional investors.
December 29, 2025 6:16 AM
Sun Pharmaceutical Industries Ltd on the Rise Today, up 0.07%
The share price of Sun Pharmaceutical Industries Ltd recently experienced a positive upturn, resulting in a 0.07% increase. Presently, it is actively trading at 1720.70.
December 29, 2025 5:15 AM
Sun Pharmaceutical Industries Ltd Shares Flat, Market Awaits Direction
There was no shift in the share price of Sun Pharmaceutical Industries Ltd, which stands at 1719.50. This static period invites investors to consider the stock's fundamental strengths and weaknesses.